These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

881 related items for PubMed ID: 9815716

  • 1. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I, Scher HI, Zhang ZF, Pellicer I, Hamza R, Eissa S, Khaled H, Cordon-Cardo C.
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [Abstract] [Full Text] [Related]

  • 2. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [Abstract] [Full Text] [Related]

  • 3. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C.
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C, Moore L, Allard P, Larue H, Lacombe L, Têtu B, Meyer F, Fradet Y.
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.
    Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C.
    Clin Cancer Res; 1999 Aug; 5(8):2082-8. PubMed ID: 10473090
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
    Kanavaros P, Bai M, Stefanaki K, Poussias G, Rontogianni D, Zioga E, Gorgoulis V, Agnantis NJ.
    Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abnormal expression of MDM2 in prostate carcinoma.
    Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carvalho CM, Meirelles MI, Santana I, Camara-Lopes LH.
    Mod Pathol; 2001 May; 14(5):428-36. PubMed ID: 11353053
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 15; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 13. Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.
    Pfister C, Larue H, Moore L, Lacombe L, Veilleux C, Tetu B, Meyer F, Fradet Y.
    Int J Cancer; 2000 Jan 20; 89(1):100-4. PubMed ID: 10719738
    [Abstract] [Full Text] [Related]

  • 14. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
    Lianes P, Orlow I, Zhang ZF, Oliva MR, Sarkis AS, Reuter VE, Cordon-Cardo C.
    J Natl Cancer Inst; 1994 Sep 07; 86(17):1325-30. PubMed ID: 8064890
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED, Matteson J, Jacobs SC, Kyprianou N.
    J Urol; 1996 Jan 07; 155(1):316-20. PubMed ID: 7490878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P, Stefanaki K, Rontogianni D, Darivianaki K, Vlychou M, Papadaki E, Eliopoulos G, Bakiri M, Matsouka C, Kakolyris S, Georgoulias V.
    Clin Exp Pathol; 1999 Jan 07; 47(5):231-8. PubMed ID: 10598372
    [Abstract] [Full Text] [Related]

  • 19. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
    Xu QZ, Liu F, Lu DH, Yu SZ, Yang H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug 07; 23(4):341-5. PubMed ID: 12940073
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.